Recent scientific discoveries are opening up exciting opportunities for scientists in the field of personalised healthcare.

This is a blog and custom podcast on behalf of AstraZeneca. AstraZeneca retain sole responsibility for this content.

Maria Orr{credit}AstraZeneca{/credit}

Thorsten Gutjahr{credit}AstraZeneca{/credit}

Dr Maria Orr is a molecular geneticist by training.

Dr Thorsten Gutjahr is a molecular biologist by training.

Both of them have successfully made the transition from academia to industry and are now leading the charge to bring innovative targeted medicines to the patients who will benefit most.

Personalised healthcare (PHC) aims to deliver the right treatment to the right patient through the use of companion diagnostics, clinical indicators or other diagnostic tools. Recent scientific progress made in PHC is remarkable and Dr Gutjahr and Dr Orr are operating at the sharp end, translating the latest scientific discoveries into clinical benefits for patients. Continue reading →